🇺🇸 Prasugrel based short DAPT in United States

Prasugrel based short DAPT (Prasugrel based short DAPT) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Prasugrel based short DAPT in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Prasugrel based short DAPT approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Prasugrel based short DAPT in United States?

Research Maatschap Cardiologen Rotterdam Zuid is the originator. The local marketing authorisation holder may differ — check the official source linked above.